Literature DB >> 25250480

Feasibility and clinical utility of ultra-widefield indocyanine green angiography.

Michael A Klufas1, Nicolas A Yannuzzi, Claudine E Pang, Sowmya Srinivas, Srinivas R Sadda, K Bailey Freund, Szilárd Kiss.   

Abstract

PURPOSE: To evaluate the feasibility and clinical utility of a novel noncontact scanning laser ophthalmoscope-based ultra-widefield indocyanine green angiographic system.
METHODS: Ultra-widefield indocyanine green angiographic images were captured using a modified Optos P200Tx that produced high-resolution images of the choroidal vasculature with up to a 200° field. Ultra-widefield indocyanine green angiography was performed on patients with a variety of retinal conditions to assess utility of this imaging technique for diagnostic purposes and disease treatment monitoring.
RESULTS: Ultra-widefield indocyanine green angiography was performed on 138 eyes of 69 patients. Mean age was 58 ± 16.9 years (range, 24-85 years). The most common ocular pathologies imaged included central serous chorioretinopathy (24 eyes), uveitis (various subtypes, 16 eyes), age-related macular degeneration (12 eyes), and polypoidal choroidal vasculopathy (4 eyes). In all eyes evaluated with ultra-widefield indocyanine green angiography, high-resolution images of choroidal and retinal circulation were obtained with sufficient detail out to 200° of the fundus.
CONCLUSION: In this series of 138 eyes, scanning laser ophthalmoscope-based ultra-widefield indocyanine green angiography was clinically practical and provided detailed images of both the central and peripheral choroidal circulation. Future studies are needed to refine the clinical value of this imaging modality and the significance of peripheral choroidal vascular changes in the diagnosis, monitoring, and treatment of ocular diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25250480     DOI: 10.1097/IAE.0000000000000318

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

Review 1.  Clinical application of ultra-widefield fundus autofluorescence.

Authors:  Amin Xu; Changzheng Chen
Journal:  Int Ophthalmol       Date:  2020-10-11       Impact factor: 2.031

2.  A new potential risk factor for central serous chorioretinopathy: blood pressure variability.

Authors:  Mehmet Fatih Karadağ
Journal:  Eye (Lond)       Date:  2020-10-19       Impact factor: 4.456

3.  Three-dimensional choroidal vascularity index in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography angiography.

Authors:  Qiaozhu Zeng; Lan Luo; Yuou Yao; Shu Tu; Zhi Yang; Mingwei Zhao
Journal:  Front Med (Lausanne)       Date:  2022-09-07

Review 4.  Antecedents of Soft Drusen, the Specific Deposits of Age-Related Macular Degeneration, in the Biology of Human Macula.

Authors:  Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-20       Impact factor: 4.799

Review 5.  Optical coherence tomography angiography in diabetic retinopathy: a review of current applications.

Authors:  Kai Yuan Tey; Kelvin Teo; Anna C S Tan; Kavya Devarajan; Bingyao Tan; Jacqueline Tan; Leopold Schmetterer; Marcus Ang
Journal:  Eye Vis (Lond)       Date:  2019-11-18

Review 6.  Wide-field angiography in retinal vein occlusions.

Authors:  Colin S Tan; Kelvin Z Li; SriniVas R Sadda
Journal:  Int J Retina Vitreous       Date:  2019-12-12

7.  Comparisons of Effective Fields of Two Ultra-Widefield Ophthalmoscopes, Optos 200Tx and Clarus 500.

Authors:  Yoshitsugu Matsui; Atsushi Ichio; Asako Sugawara; Eriko Uchiyama; Hitomi Suimon; Hisashi Matsubara; Masahiko Sugimoto; Kengo Ikesugi; Mineo Kondo
Journal:  Biomed Res Int       Date:  2019-12-05       Impact factor: 3.411

8.  Quantitative Assessment of Asymmetric Choroidal Outflow in Pachychoroid Eyes on Ultra-Widefield Indocyanine Green Angiography.

Authors:  Jesse J Jung; Daryle Jason G Yu; Kazuyo Ito; Soraya Rofagha; Scott S Lee; Quan V Hoang
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.